LOS ANGELES–(BUSINESS WIRE)–Eine der größten Diabetes-Klinken Deutschlands überprüft jährlich 20.000 Patienten mit AI-unterstütztem Augen-Screening-System EyeArt auf diabetische
Author: Business Wire
Verseon Showcases Candidates for Next-Generation Diabetic Eye Disease Drugs
FREMONT, Calif.–(BUSINESS WIRE)–<a href="https://twitter.com/hashtag/biotech?src=hash" target="_blank">#biotech</a>–Verseon presented their oral drug candidates for diabetic macular edema (DME) at this week’s 2019 BIO…
WaveOptics與和碩在擴增實境世界博覽會和PEGATRON Day期間展示AiR眼鏡原型
加州聖荷西–(BUSINESS WIRE)–(美國商業資訊)–衍射波導元件的領先設計商和製造商WaveOptics和世界級製造服務提供者和碩聯合科技股份有限公司(PEGATRON)正在擴增實境世界博覽會(AWE)和PEGATRON Day上展示AiR原型眼鏡。 WaveOptics與和碩還建立了策略合作夥伴關係，為快速發展的AR市場開發AR穿戴式裝置。 和碩正與WaveOptics合作開發和碩最新的AR眼鏡原型AiR，以滿足工業、醫療和商業三大主要應用領域的需求。這種眼鏡可以為各個領域的專業人…
波光与和硕在增强现实世界博览会和和硕日期间展示AiR眼镜原型
加州圣何塞–(BUSINESS WIRE)–(美国商业资讯)–衍射波导元件的领先设计商和制造商波光(WaveOptics)和世界级制造服务提供商和硕联合科技股份有限公司(PEGATRON)正在增强现实世界博览会(AWE)和和硕日(PEGATRON Day)上展示AiR原型眼镜。 波光与和硕还建立了战略合作伙伴关系，为快速发展的AR市场开发AR可穿戴设备。 和硕正与波光合作开发和硕最新的AR眼镜原型AiR，以满足工业、医疗和商业三大主要应用领域的需求。这种眼镜可以为各个领域的专业人员提供即时AR…
OptiKira Awarded Phase II SBIR Grant
CLEVELAND–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/BioMotiv?src=hash" target="_blank"gt;#BioMotivlt;/agt;–OptiKira announced today that it was awarded a Phase II SBIR grant to support continued devel…
Ocular Therapeutix™ to Present at Three Upcoming Investor Conferences
BEDFORD, Mass.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24OCUL&src=ctag" target="_blank"gt;$OCULlt;/agt; lt;a href="https://twitter.com/hashtag/OCUTX?src=hash" target=&…
WaveOptics and PEGATRON Demonstrate AiR Glasses Prototype at Both AWE and PEGATRON Day
SAN JOSE, Calif.–(BUSINESS WIRE)–WaveOptics and PEGATRON, are demonstrating a prototype AiR glasses at both AWE and PEGATRON Day.
Fabrinet to Present at Upcoming Investor Conferences
BANGKOK–(BUSINESS WIRE)–Fabrinet (NYSE: FN), a leading provider of advanced optical packaging and precision optical, electro-mechanical and electronic manufacturing services to original equipment manufacturers of complex products, today announced tha…
Global Optical Biometry Devices Market 2019-2023 with Carl Zeiss Meditec, Menicon, Metall Zug, NIDEK, Santec, & Topcon Dominating – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Optical Biometry Devices Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering. The optical biometry devices market will register a CAGR of almost 6% by 2023. The rise in the prevalence of cataract among geriatric population is one of the key factors that will trigger the growth of the market during the forecast period. The older population are willing to lead a more active lifestyle and take care of their health and vision, which is l
Global Surgical Lasers Market to Surpass US$ 2 Billion by 2026 – Coherent Market Insights
SEATTLE–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/DiodeLaser?src=hash" target="_blank"gt;#DiodeLaserlt;/agt;–According to Coherent Market Insights, the global surgical lasers market was valued at US$ …
Ocular Therapeutix™ Announces Receipt of C-Code and Pass-Through Payment Status for DEXTENZA®
BEDFORD, Mass.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24OCUL&src=ctag" target="_blank"gt;$OCULlt;/agt; lt;a href="https://twitter.com/hashtag/OCUTX?src=hash" target=&…
Des leaders d’opinion concluent que l’amélioration bilatérale durable observée dans l’étude clinique de Phase III REVERSE de GenSight Biologics représente un bénéfice thérapeutique sans précédent pour les patients
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext : SIGHT, ISIN : FR0013183985, éligible PEA-PME), société biopharmaceutique dédiée à la découverte et au développement de thérapies géniques innovantes pour le traitement des maladies…
Sustained Bilateral Improvement from GenSight Biologics’ REVERSE Phase III Clinical Trial Represents Transformative Therapeutic Benefit for Patients, Key Opinion Leaders Conclude
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on discovering and developing innovative gene therapies for retinal neurodegenerative diseases and central …
SightLife Announces 100,000 Corneal Transplants in India Since Program Inception in 2009
NEW DELHI, India–(BUSINESS WIRE)–100,000 individuals suffering from corneal blindness have had their sight restored by SightLife and its partners in India in the past 10 years.
Global Eye Allergy Therapeutics Market Report 2019-2023 Featuring Akorn, Allergan, Bausch Health Companies, Novartis, & Santen Pharmaceutical – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Eye Allergy Therapeutics Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering. This is expected to propel the growth of the market during the forecast period. Analysts have predicted that the eye allergy therapeutics market will register a CAGR of almost 5% by 2023. The global eye allergy therapeutics market is currently witnessing a high unmet medical need for a once-daily double-action eye preparation for the treatment of various ty
Delray Eye Associates Enters Strategic Partnership with EyeCare Services Partners
DALLAS–(BUSINESS WIRE)–Delray Eye Associates (“DEA”), one of the leading comprehensive eye care providers in South Florida, has entered into a strategic partnership with EyeCare Services Partners Management, LLC (“ESP”), the leading national provider…
Aerie Pharmaceuticals to Present at the Jefferies 2019 Healthcare Conference
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucom…
Aura Biosciences to Present at the Jefferies 2019 Global Healthcare Conference
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Aura Biosciences today announced that CEO Elisabet de los Pinos, Ph.D., will present at the Jefferies 2019 Global Healthcare Conference.
Global Ophthalmology Market by Segment, Disease, Drug Class, and Region – Outlook to 2025 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Ophthalmology Market by Segment, Disease, Drug Class, and Region – Outlook to 2025” report has been added to ResearchAndMarkets.com’s offering. Treatment paradigm of eye disorders primarily aims to reduce inflammation, repairs traumatic injuries, and improves or saves eyesight. Treatment comprises of medication, surgery, prescription glasses or contact lenses and treatment of systemic conditions affecting the eye. Prevalence of eye disorders has been increas
Glaukos Announces Participation in William Blair Growth Stock Conference
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies desig…